CN117660496A - Rhamnosyltransferase SGT822 and application thereof - Google Patents
Rhamnosyltransferase SGT822 and application thereof Download PDFInfo
- Publication number
- CN117660496A CN117660496A CN202311635725.3A CN202311635725A CN117660496A CN 117660496 A CN117660496 A CN 117660496A CN 202311635725 A CN202311635725 A CN 202311635725A CN 117660496 A CN117660496 A CN 117660496A
- Authority
- CN
- China
- Prior art keywords
- sgt822
- rhamnosyltransferase
- nos
- rhamnosyl
- nosiheptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004357 Transferases Human genes 0.000 claims abstract description 16
- 108090000992 Transferases Proteins 0.000 claims abstract description 16
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 230000013595 glycosylation Effects 0.000 claims description 4
- 238000006206 glycosylation reaction Methods 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims 2
- 238000003259 recombinant expression Methods 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- FPTCMHOCGKKRGQ-WYOWUDGCSA-N Multhiomycin Natural products CC=C1NC(=O)[C@@H](NC(=O)c2csc(n2)c3cc(O)c(nc3c4csc(n4)[C@H]5CSC(=O)c6[nH]c7cccc(COC(=O)[C@@H](O)C[C@H](NC(=O)c8csc1n8)c9nc(cs9)C(=O)N5)c7c6C)c%10nc(cs%10)C(=O)N[C@@H](C)C(=O)N)[C@H](C)O FPTCMHOCGKKRGQ-WYOWUDGCSA-N 0.000 abstract description 20
- 101800003864 Nosiheptide Proteins 0.000 abstract description 20
- 229950006423 nosiheptide Drugs 0.000 abstract description 20
- MQWDKYHFGBWGQZ-JQTJYXGUSA-N nosiheptide Chemical compound N([C@H](C(=O)N\C(C=1SC=C(N=1)C(=O)N[C@@H]1CC(O)C(=O)OCC=2C=CC=C3NC(=C(C3=2)C)C(=O)SC[C@H](NC(=O)C=2N=C1SC=2)C=1SC=C(N=1)C1=N2)=C/C)[C@@H](C)O)C(=O)C(N=3)=CSC=3C1=CC(=O)\C2=C1/NC(C(=O)NC(=C)C(N)=O)=CS1 MQWDKYHFGBWGQZ-JQTJYXGUSA-N 0.000 abstract description 19
- 230000004048 modification Effects 0.000 abstract description 9
- 238000012986 modification Methods 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 241000187180 Streptomyces sp. Species 0.000 abstract description 3
- 230000002255 enzymatic effect Effects 0.000 abstract description 3
- 229930014626 natural product Natural products 0.000 abstract 1
- 230000006172 rhamnosylation Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 24
- 230000000694 effects Effects 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 239000012634 fragment Substances 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 5
- 229910021645 metal ion Inorganic materials 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- ZOSQFDVXNQFKBY-CGAXJHMRSA-N dTDP-beta-L-rhamnose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)C[C@H](N2C(NC(=O)C(C)=C2)=O)O1 ZOSQFDVXNQFKBY-CGAXJHMRSA-N 0.000 description 4
- 238000001976 enzyme digestion Methods 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960003085 meticillin Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- UQBOJOOOTLPNST-UHFFFAOYSA-N Dehydroalanine Chemical group NC(=C)C(O)=O UQBOJOOOTLPNST-UHFFFAOYSA-N 0.000 description 1
- 102000051366 Glycosyltransferases Human genes 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 238000010268 HPLC based assay Methods 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000933218 Streptomyces parvus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000007986 glycine-NaOH buffer Substances 0.000 description 1
- 230000001279 glycosylating effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 108091005601 modified peptides Proteins 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 1
- 239000012536 storage buffer Substances 0.000 description 1
- 150000003463 sulfur Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a rhamnosyl transferase SGT822 and application thereof. The applicant screens from Streptomyces sp.147326 to obtain rhamnosyl transferase SGT822, can glycosylate and modify the nosiheptide to generate rhamnosyl nosiheptide, greatly improves the water solubility of the nosiheptide, explains the modifiable property of NOS pyridine ring hydroxyl, provides a new site for the structural modification of NOS, and provides a new enzymatic element for the rhamnosylation modification of natural products.
Description
Technical Field
The invention relates to rhamnosyl transferase, in particular to rhamnosyl transferase SGT822 and application thereof.
Background
The thiopeptides antibiotic belongs to ribosomal synthesis and post-translational modification peptides (Ribosome synthesis andpost translational modifiedpeptides, ripps), a heterocyclic peptide antibiotic with high modification produced by a variety of bacteria. Consists of a central pyridine ring, a core macrocycle and a tail (Bagley MC, et al J. Chem Rev.2005Feb;105 (2): 685-714).
The structure of the nosiheptide is as follows
Nosiheptide (NOS) belongs to the e-series of sulfur peptide parent compounds, and was originally isolated from Streptomyces parvus, and exhibits excellent antibacterial activity against all methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus currently, and has been the mainstream of the study of sulfur peptide antibiotics due to its structural representativeness (Haste NM, et al J.Antiboot (Tokyo) 2012Dec;65 (12): 593-8.). Although NOS has super-strong antibacterial activity, the disadvantages of poor water solubility and no in vivo activity limit the development and clinical application of the patent medicine, and structural transformation to obtain analogues with various structures becomes one of the important means for improving the patentability of NOS. However, NOS is too complex in structure, extremely difficult to modify, few examples of successful modification exist, and modification of dehydroalanine side chains and side rings is concentrated.
In the structure of NOS, the hydroxyl group of the core pyridine ring has excellent reactivity, and is an ideal structural modification site. The water solubility of the rhamnoylated norcetin is enhanced by glycosylating the pyridine ring hydroxyl of the norcetin with a rhamnotransferase to form the rhamnoylated norcetin.
Disclosure of Invention
The invention aims to provide a rhamnosyl transferase SGT822 and application thereof, wherein the rhamnosyl transferase SGT822 can realize the regioselective glycosylation modification of NOS pyridine ring hydroxyl. In order to achieve the above purpose, the technical scheme adopted by the invention is as follows:
1) The rhamnosyltransferase is SGT822 derived from Streptomyces sp.147326.
2) A rhamnosyl transferase SGT822, the nucleotide sequence of said rhamnosyl transferase SGT822 being as set forth in seq id NO:1, high efficiency catalyzing the formation of rhamnosylated norcetin from norcetin.
3) The rhamnosyltransferase SGT822 constructs a plasmid.
4) The rhamnosyltransferase SGT822 may be expressed in E.coli BL21 (DE 3) independently or in a co-expression, and the heterologous expression host is only an example, and the rhamnosyltransferase may be expressed in lactic acid bacteria, streptomyces, yeast, bacillus subtilis, etc., without limiting the scope of the present invention.
5) The present invention provides a rhamnosyl transferase which has the reactivity of catalyzing the conversion of a nosiheptide into a rhamnosylated nosiheptide.
The invention has the following advantages:
the invention discovers that the rhamnosyl transferase SGT822 from natural microorganism is a brand new enzyme, the structure of the enzyme is not reported in the literature, the enzyme has the function of directionally modifying the pyridine ring hydroxyl of the norcetylpeptides to form the rhamnosylated norcetylpeptides, namely, the two hydroxyl groups exist in NOS, the rhamnose can be modified by the regional selective glycosylation of the pyridine ring hydroxyl of NOS, and the 3-position light group of the other threonine is not affected.
Improves the water solubility of the norcetirin and provides a new method for improving the water solubility of the series of other compounds by utilizing the modification of the site.
Drawings
FIG. 1 is an HPLC assay of SGT822 to catalyze NOS;
FIG. 2 is a graph showing the effect of reaction pH on SGT 822;
FIG. 3 is a graph showing the effect of reaction temperature on SGT 822;
FIG. 4 is a graph showing the effect of temperature stability (A) and pH stability (B) on SGT 822;
FIG. 5 is a graph showing the effect of metal ions on SGT 822;
FIG. 6 is a graph of the Miq equation for SGT822 glycosylation modification of a northwest peptide to produce a rhamnosylated northwest peptide;
FIG. 7 is an elution profile of SGT822 over Superdex 200;
FIG. 8 is a schematic representation of pET22b-SGT822 plasmid.
Detailed Description
The advantages and various effects of the present invention will be more clearly apparent from the following detailed description and examples. It will be understood by those skilled in the art that these specific embodiments and examples are intended to illustrate the invention, not to limit the invention.
EXAMPLE 1 construction of pET22b-SGT822 expression plasmid
(a) Acquisition of the Gene of interest
The Streptomyces sp.147326 genome was obtained by a kit extraction method, specific primers were designed as shown in Table 1, DNA fragments of SGT822 target sequences were obtained by PCR amplification, and were recovered and purified by gel.
TABLE 1 SGT822 specific primers
(b) Cleavage of the fragment of interest and the vector
The target fragment and the vector were digested with restriction endonucleases, and the cleavage system is shown in Table 2. After mixing, the enzyme digestion system is incubated for 1h in a 37 ℃ incubator, enzyme digestion products are separated by 1% agarose gel electrophoresis, the electrophoresis voltage is 120V, the electrophoresis time is 30min, and the enzyme digestion fragments are recovered by using a gel recovery kit.
TABLE 2 enzyme digestion system
(c) Fragment of interest and vector ligation
The target fragment after cleavage and recovery was ligated to a linear vector, and the ligation system was shown in Table 3. After mixing, the system was placed in a 16 ℃ incubator and connected for 12h. A schematic representation of the pET22b-SGT822 plasmid is shown in FIG. 8.
TABLE 3 ligation System of fragments of interest with vector
EXAMPLE 2 protein expression and purification of pET22b-SGT822 plasmid
(a) Construction of expression strains
The pET22b-SGT822 plasmid was transformed into E.coli competent DH 5. Alpha. And sequenced to obtain the correct plasmid pET22b-SGT822. Transformation of pET22b-SGT822 plasmid into E.coli protein expression competent
BL21(DE3)。
(b) Inducible expression of rhamnosyl transferase SGT822
Selecting monoclonal strain, shake culturing in liquid LB culture medium at 37deg.C and 220rpm to OD 600 =0.6,
IPTG was added at a final concentration of 0.5mM and induction was carried out at 20℃for 12 hours. After the induction is finished, the bacterial cells are collected,
the cells were resuspended in 50mM Tris-HCl and collected by centrifugation again.
(c) Purification of rhamnosyltransferase SGT822
5g of the cells were weighed and added to 50mL of Tris-HCl buffer solution to mix well. And crushing the cells by using an ultrasonic crusher, collecting the supernatant, and purifying by using nickel affinity chromatography to obtain the SGT822 rhamnosyl transferase.
Example 4 functional verification of rhamnosyltransferase SGT822
Verification of rhamnosyl transferase SGT822 function was performed according to the reaction system shown in Table 4 where NOS is acceptor and dTDP-L-rhamnose (dTR) is sugar donor. After reaction at 30℃for 6 hours at 100rpm, 500. Mu.L of methanol and 500. Mu.L of DMSO were added and mixed uniformly to terminate the reaction, the mixture was centrifuged at 12000rpm for 10 minutes, and then filtered through a 0.22 μm organic filter membrane, and the reaction mixture was subjected to HPLC detection using NOS-R as a positive control, the detection result being shown in FIG. 1.
TABLE 4 glycosyltransferase reaction System
EXAMPLE 5 rhamnosyltransferase SGT822 enzymatic Studies (a) enzymatic Property determination
1. Optimal reaction pH
The reaction system was set to a final concentration of 1mg/mL of NOS, 20. Mu.L of SGT822 obtained in example 3 and 100. Mu.L of dTR, three parallel experiments were performed for each sample, and after the completion of the reaction, HPLC detection was performed to examine the change in substrate conversion in the pH range of 6 to 11. As shown in FIG. 2, at a reaction pH of between 6 and 10, the yield increased with increasing pH, and at pH 10, the conversion reached a maximum of 39.1% with 50mM Glycine-NaOH as the buffer. In addition, the enzyme activity is affected by the difference of the buffer used at the same pH, and the enzyme activity is affected minimally by Tris.
2. Optimum reaction temperature
The change of the conversion rate of the substrate in the range of 25-70 ℃ is examined, and the reaction system is the same as above. As shown in FIG. 3, the reaction temperature is increased between 25 and 55 ℃, the yield is increased, the conversion rate reaches the highest at 55 ℃, 73.2%, the temperature is continuously increased, the yield is obviously reduced, and the yield is only 13.3% at 70 ℃.
3. Temperature stability and pH stability
As shown in FIG. 4, SGT822 has better stability at 4deg.C, there is no significant change in enzyme activity after 12 hours of standing, and stability at 30deg.C is poorer than that at 4deg.C. After 12h in 50mM Glycine-NaOH buffer, the enzyme activity was only lost 7%, indicating that it is suitable for use as a storage buffer for SGT822.
4. Influence of metal ions
EDTA and Mg with final concentration of 5mM are added 2+ 、Mn 2+ 、Zn 2+ 、Fe 3+ 、Cu 2+ 、Ca 2+ 、K + 、Na + Ni and 2+ the rest reaction systems are the same, the reaction is carried out at the optimal temperature and pH of the enzyme, and the relative ratio is calculated by taking the substrate conversion rate of the reaction of the control group without adding metal ions as a standardActivity. As shown in FIG. 5, mg 2+ The enzyme activity is increased by about 1.3 times, and the metal ion chelating agent EDTA reduces the enzyme activity by half. Other metal ions all have various degrees of inhibition on SGT822, mn 2+ 、Ca 2+ 、K + Na (sodium carbonate) + The influence on the enzyme activity is weak, and Cu 2+ Has the strongest inhibition effect, and can lead the enzyme activity to lose about 97 percent (b) the determination of the kinetic parameters of the SGT822 of the rhamnosyl transferase
The kinetic parameters of the individual substrates NOS were determined, the amount of immobilized dTR was 100. Mu.L, the final concentration of NOS was set between 0.0156 and 2mM, and the reaction was carried out at optimum temperature and pH for 45min. As shown in FIG. 6, the curve after nonlinear fitting has a maximum reaction rate Vmax of 1.465.+ -. 0.049. Mu.M/min, a Mie constant Km of 107.22.+ -. 13.38. Mu.M, and a catalytic constant Kcat of 0.033.+ -. 0.001min -1 Kcat/Km of 3.07×10 -3 min -1 μM -1 。
EXAMPLE 6 rhamnosyltransferase SGT822 active form
The gel chromatography is used to separate the monomer and oligomer with large molecular weight difference, and the protein with large molecular weight is washed out before the protein with small molecular weight. The elution results are shown in FIG. 7, where there are two peaks at 280nm, the first peak is multimeric and the second peak is monomeric, by the control protein standard curve. The activity was verified after collecting the monomer and the multimer separately, and the results showed that the monomer was active and the multimer was inactive. Embodiment 7 rhamnosyltransferase SGT822 catalytic residue positioning
The conserved residues His13 and Asp308 were selected as mutation sites, which were mutated to alanine using a site-directed mutagenesis kit, the primers required for this procedure are shown in Table 5 (bolded bases are mutation sites), and the PCR procedure is shown in Table 6. As shown in the following formula, his13 and Asp308 are not necessarily catalytic, and act as catalytic diads.
TABLE 5 primers for alanine mutations
TABLE 6 PCR amplification procedure
Claims (5)
1. The rhamnosyl transferase SGT822 is characterized in that the nucleotide sequence of the rhamnosyl transferase SGT822 is shown in SEQ ID NO.1, and the amino acid sequence is shown in SEQ ID NO. 2.
2. A recombinant expression vector comprising the nucleotide sequence of rhamnosyltransferase SGT822 of claim 1.
3. An engineered host cell, wherein the recombinant bacterium or engineered host cell line comprises the recombinant expression vector of claim 2.
4. The engineered host cell of claim 3, wherein the host cell is e.
5. Use of a rhamnosyltransferase SGT822 according to claim 1 or a host cell according to claim 3 or 4 for the synthesis of rhamnosylated norcetin from glycosylation modified norcetin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311635725.3A CN117660496A (en) | 2023-12-01 | 2023-12-01 | Rhamnosyltransferase SGT822 and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311635725.3A CN117660496A (en) | 2023-12-01 | 2023-12-01 | Rhamnosyltransferase SGT822 and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117660496A true CN117660496A (en) | 2024-03-08 |
Family
ID=90078297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311635725.3A Pending CN117660496A (en) | 2023-12-01 | 2023-12-01 | Rhamnosyltransferase SGT822 and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117660496A (en) |
-
2023
- 2023-12-01 CN CN202311635725.3A patent/CN117660496A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109182284B (en) | 7 beta-hydroxysteroid dehydrogenase mutant, coding sequence, recombinant expression vector, genetic engineering bacteria and application | |
CN112301013B (en) | Complex enzyme and application thereof in preparation of ergothioneine | |
CN112342179B (en) | Bacillus subtilis genetic engineering bacteria for producing tagatose and method for preparing tagatose | |
KR102076288B1 (en) | A composition for preparing tagatose and Methods for producing tagatose using The Same | |
CN112301012B (en) | Cyclodextrin glucosyltransferase mutant and construction method thereof | |
CN108277244B (en) | Preparation of sedoheptulose and aldose by immobilized enzyme cascade reaction | |
CN112662655B (en) | Cephalosporin C acylase mutant and preparation method and application thereof | |
CN109055417B (en) | Recombinant microorganism, preparation method thereof and application thereof in production of coenzyme Q10 | |
CN117660496A (en) | Rhamnosyltransferase SGT822 and application thereof | |
WO2018171400A1 (en) | Bacterium for engineering acarbose, preparation method therefor, and application thereof | |
CN113088504B (en) | Modified acid phosphatase and application thereof | |
CN111172143B (en) | D-xylonic acid dehydratase and application thereof | |
CN112575022A (en) | Construction method of in-vitro artificial scaffold protein-mediated trehalose multienzyme complex | |
CN112251420A (en) | Bacterial levan synthetase from strict anaerobe | |
CN105349480B (en) | The recombination bacillus coli of one plant of high efficient expression [2Fe2S] ferredoxin and its application | |
CN105274042B (en) | One plant of recombination bacillus coli and its application in fermenting and producing 2 [4Fe4S] ferredoxin | |
CN112980755B (en) | Genetically engineered bacterium capable of efficiently secreting isoamylase | |
US20190048353A1 (en) | Marine bacterial gene lfliz and use | |
CN114875087B (en) | Method for synthesizing 5-hydroxy beta-indolylalanine by taking beta-indolylalanine as substrate and application thereof | |
WO2024114637A1 (en) | Engineering bacteria for producing acarbose, and construction method therefor and use thereof | |
CN116463311A (en) | Glycosyltransferase mutant and application thereof | |
CN116751773A (en) | D-psicose 3-epimerase mutant, gene and application | |
KR101294598B1 (en) | 4-alpha-Glucanotransferase-amylose complex and the applications of the same | |
KR101479134B1 (en) | A novel NADH oxidase from Streptococcus pyogenes and its coupling with L-arabinitol dehydrogenase for L-xylulose production | |
CN113621666A (en) | Method for biosynthesizing laminaribiose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |